Skin Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
Testing Adjuvant Ipilimumab in Advanced Melanoma
(Posted: 10/04/2011) - In this clinical trial, patients with stage III or stage IV melanoma that has been completely resected will be randomly assigned to receive adjuvant (post-surgical) treatment with either ipilimumab or high-dose interferon alfa-2b, the current standard of care.
Skin Cancer Prevention Study
(Posted: 05/25/2004) - Actinic keratoses (AKs) are precancerous skin growths that are usually caused by sun exposure. This study seeks to determine if the drug celecoxib prevents new AKs from developing, causes existing AKs to go away, and prevents AKs from progressing to squamous cell cancer.
(Posted: 10/04/2011) - In this clinical trial, patients with stage III or stage IV melanoma that has been completely resected will be randomly assigned to receive adjuvant (post-surgical) treatment with either ipilimumab or high-dose interferon alfa-2b, the current standard of care.
Skin Cancer Prevention Study
(Posted: 05/25/2004) - Actinic keratoses (AKs) are precancerous skin growths that are usually caused by sun exposure. This study seeks to determine if the drug celecoxib prevents new AKs from developing, causes existing AKs to go away, and prevents AKs from progressing to squamous cell cancer.